A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization

Autor: Malini Laloraya, Betcy Susan Johnson
Rok vydání: 2020
Předmět:
0301 basic medicine
ARDS
ALI
acute lung injury

animal diseases
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Co-morbidity
Disease
IL-1RA
interleukin-1 receptor antagonist

Severe Acute Respiratory Syndrome
PDGF
platelet-derived growth factor

Pulmonary Disease
Chronic Obstructive

0302 clinical medicine
MERS-CoV
middle east respiratory syndrome coronavirus

CCL
chemokine (C-C motif) ligand

bFGF
basic fibroblast growth factor

BADAS
BCG vaccine for health care workers as defense against COVID 19

Risk Factors
BALF
bronchoalveolar lavage fluid

Immunology and Allergy
BCG
TMPRSS2
transmembrane protease serine 2

COVID-19
coronavirus disease 2019

COVID-19(SARS Cov2)
ACE2
angiotensin converting enzyme 2

Vaccination
MCP-1
monocyte chemoattractant protein-1

VEGF
vascular endothelial growth factor

Mycobacterium bovis
NKT
natural killer T cells

Cytokine
Cardiovascular Diseases
030220 oncology & carcinogenesis
BCG-CORONA
reducing health care workers absenteeism in COVID-19 pandemic by enhanced trained immune responses through bacillus calmette-guérin vaccination
a randomized controlled trial

Hypertension
BCG Vaccine
Middle East Respiratory Syndrome Coronavirus
Cytokines
RANTES
regulated on activation
normal T cell expressed and secreted

GM-CSF
granulocyte-macrophage colony-stimulating factor

Coronavirus Infections
Cytokine Release Syndrome
MIP
macrophage inflammatory protein

Immunology
SARS-CoV
severe acute respiratory syndrome coronavirus

IP-10
IFN-γ-inducible protein-10

Pneumonia
Viral

MIG
Monokine induced by gamma interferon

Antiviral Agents
General Biochemistry
Genetics and Molecular Biology

Article
03 medical and health sciences
Betacoronavirus
Immune system
G-CSF/GCSF
granulocyte-colony stimulating factor

Lower respiratory tract infection
Growth Factors
TGF-β
transforming growth factor-β

T2DM
type2 diabetes

medicine
Diabetes Mellitus
Humans
IFN
interferon

Pandemics
ARDS
acute respiratory distress syndrome

ComputingMethodologies_COMPUTERGRAPHICS
business.industry
GDM
gestational diabetes mellitus

SARS-CoV-2
fungi
TNF
tumor necrosis factor
IL Interleukin

COVID-19
BCG
bacillus calmette- guérin

TH
T helper

medicine.disease
DPP4
dipeptidyl peptidase 4

BRACE
BCG vaccination to reduce the impact of COVID-19 in healthcare workers following coronavirus exposure

Coronavirus
Pneumonia
030104 developmental biology
COPD
chronic obstructive pulmonary disease

CXCL
C-X-C motif chemokine

HCoV
human coronavirus

RNA
ribonucleic acid

Cytokine storm
business
Zdroj: Cytokine & Growth Factor Reviews
ISSN: 1879-0305
Popis: Graphical abstract
Highlights • According to WHO, COVID-19 pandemic belongs to very high-risk category. • Potentially lethal manifestations of COVID-19 are due to cytokine storm syndrome. • Cytokine storm in COVID-19 patients with co-morbidities is associated with elevated cytokine synergism. • Exacerbation of ‘cytokine storm’ in high risk patients could be responsible for the high mortality. • Antiviral state imparted by BCG vaccine confers early protection against SARS-CoV2. • Trained immunity of BCG vaccine involves the release of cytokine IL-1β, TNF-α and IL-6 from epigenetically modified monocytes.
The seventh human coronavirus SARS-CoV2 belongs to the cluster of extremely pathogenic coronaviruses like SARS-CoV and MERS-CoV, which are established to cause lower respiratory tract infection. The viral infection can be fatal as the disease advances to pneumonia followed by acute respiratory distress syndrome (ARDS). Increasingly higher cytokine concentration on account of over-stimulated immune response against the virus, or the ‘cytokine storm’, is the reason behind the manifestation of lethal clinical symptoms. In this article, we discuss the immune pathogenesis of cytokine storm and its relation with SARS-CoV2/COVID-19 risk factors. People with underlying risk factors are more susceptible to fatal complications of COVID-19 infection leading to poor clinical outcome. The increased pro-inflammatory immune status in patients with risk factors (diabetes, hypertension, cardiovascular disease, COPD) exacerbates the Cytokine-storm of COVID-19 to a Cytokine Super Cyclone. We also overviewed antiviral immune response provided by BCG vaccine involving the IL-1β, IL-6 and TNF-α secretion via ‘trained monocytes’, which confers early protection against SARS-CoV2.
Databáze: OpenAIRE